I am a patient, caregiver, or health care provider. Where do I go for support?
ucbCARES stands ready to help anyone impacted by COVID-19 find answers to their questions and ensuring they receive the respect and care they deserve during this concerning time.Read More
What is UCB's approach to clinical trials during this time?
In March 2020, the evolving COVID-19 pandemic led UCB to halt recruitment into ongoing clinical studies and delay all new study starts. This decision was taken in the interest of public health safety and to help reduce the strain on healthcare systems across the world during a time of extraordinary medical emergency. As of mid-May 2020, UCB began to restart clinical study recruitment, including new study starts, at clinical trials sites that meet our restart criteria.Read More
UCB continues to proactively monitor the COVID-19 situation and will take any necessary precautionary steps in the interest of public health. Healthcare professionals and patients with questions related to UCB medicines can contact UCBCares / UCB Medical Information teams across the globe. Contact details can be found here.
I am facing hardship due to the COVID-19 pandemic and experiencing difficulty affording UCB medicines due to job loss, job furlough, or loss of insurance coverage. Where can I go for help?
We have expanded our existing Patient Assistance Program (PAP) to help eligible patients who have been impacted by COVID-19 by expediting enrollment to help ensure uninterrupted access to their medicines at no cost.Read More
Is UCB experiencing shortages for any of UCB's products due to COVID-19?
We are committed to assuring reliable supply of medicines in every market where we have a commercial presence.Read More
Despite the rapid emergence of the novel coronavirus and the challenge presented to healthcare systems around the globe, UCB has not experienced shortages for any of our products due to this epidemic.